Ryan Zimmerman
Stock Analyst at BTIG
(3.99)
# 611
Out of 5,015 analysts
198
Total ratings
51.85%
Success rate
11.01%
Average return
Main Sectors:
Stocks Rated by Ryan Zimmerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYK Stryker | Maintains: Buy | $407 → $408 | $364.60 | +11.90% | 16 | Oct 13, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Buy | $118 → $122 | $94.71 | +28.81% | 8 | Oct 13, 2025 | |
| ALC Alcon | Maintains: Buy | $92 → $91 | $72.05 | +26.30% | 12 | Oct 13, 2025 | |
| GKOS Glaukos | Maintains: Buy | $118 → $104 | $82.56 | +25.97% | 12 | Oct 13, 2025 | |
| HUMA Humacyte | Maintains: Buy | $7 → $6 | $1.56 | +284.62% | 5 | Oct 13, 2025 | |
| ISRG Intuitive Surgical | Maintains: Buy | $571 → $529 | $429.59 | +23.14% | 20 | Oct 13, 2025 | |
| KIDS OrthoPediatrics | Maintains: Buy | $39 → $23 | $16.30 | +41.10% | 9 | Oct 10, 2025 | |
| ORGO Organogenesis Holdings | Reiterates: Buy | $7 | $3.96 | +76.77% | 7 | Sep 26, 2025 | |
| VCEL Vericel | Downgrades: Neutral | n/a | $31.85 | - | 9 | Sep 17, 2025 | |
| PRCT PROCEPT BioRobotics | Reiterates: Neutral | n/a | $32.92 | - | 2 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $12.39 | +85.63% | 1 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $145 → $148 | $132.57 | +11.64% | 7 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.51 | - | 5 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $56.57 | - | 15 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $232 → $270 | $260.49 | +3.65% | 19 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $13.34 | - | 6 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $100 | $71.01 | +40.83% | 2 | Sep 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $70.52 | - | 1 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $53 | $26.68 | +98.65% | 7 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2 → $3 | $0.72 | +319.23% | 2 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.88 | - | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.14 | - | 3 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $2.23 | +79.37% | 1 | Jan 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.84 | - | 3 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $14.20 | - | 2 | Sep 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $28 | $14.22 | +96.91% | 4 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $200 | $144.64 | +38.27% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $340 → $350 | $314.52 | +11.28% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $128 | $95.45 | +34.10% | 4 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $11.89 | +26.16% | 1 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $91 | $67.76 | +34.30% | 1 | Feb 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $18.17 | +131.15% | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $53 | $5.00 | +950.00% | 3 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $15.99 | - | 3 | Apr 2, 2020 |
Stryker
Oct 13, 2025
Maintains: Buy
Price Target: $407 → $408
Current: $364.60
Upside: +11.90%
Zimmer Biomet Holdings
Oct 13, 2025
Maintains: Buy
Price Target: $118 → $122
Current: $94.71
Upside: +28.81%
Alcon
Oct 13, 2025
Maintains: Buy
Price Target: $92 → $91
Current: $72.05
Upside: +26.30%
Glaukos
Oct 13, 2025
Maintains: Buy
Price Target: $118 → $104
Current: $82.56
Upside: +25.97%
Humacyte
Oct 13, 2025
Maintains: Buy
Price Target: $7 → $6
Current: $1.56
Upside: +284.62%
Intuitive Surgical
Oct 13, 2025
Maintains: Buy
Price Target: $571 → $529
Current: $429.59
Upside: +23.14%
OrthoPediatrics
Oct 10, 2025
Maintains: Buy
Price Target: $39 → $23
Current: $16.30
Upside: +41.10%
Organogenesis Holdings
Sep 26, 2025
Reiterates: Buy
Price Target: $7
Current: $3.96
Upside: +76.77%
Vericel
Sep 17, 2025
Downgrades: Neutral
Price Target: n/a
Current: $31.85
Upside: -
PROCEPT BioRobotics
Sep 16, 2025
Reiterates: Neutral
Price Target: n/a
Current: $32.92
Upside: -
Sep 9, 2025
Reiterates: Buy
Price Target: $23
Current: $12.39
Upside: +85.63%
Jul 14, 2025
Maintains: Buy
Price Target: $145 → $148
Current: $132.57
Upside: +11.64%
Jul 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $7.51
Upside: -
May 27, 2025
Downgrades: Neutral
Price Target: n/a
Current: $56.57
Upside: -
Nov 26, 2024
Maintains: Buy
Price Target: $232 → $270
Current: $260.49
Upside: +3.65%
Oct 7, 2024
Upgrades: Neutral
Price Target: n/a
Current: $13.34
Upside: -
Sep 18, 2024
Upgrades: Buy
Price Target: $100
Current: $71.01
Upside: +40.83%
Sep 5, 2024
Initiates: Neutral
Price Target: n/a
Current: $70.52
Upside: -
Jul 15, 2024
Maintains: Buy
Price Target: $46 → $53
Current: $26.68
Upside: +98.65%
May 16, 2024
Maintains: Buy
Price Target: $2 → $3
Current: $0.72
Upside: +319.23%
May 8, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.88
Upside: -
Apr 11, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.14
Upside: -
Jan 23, 2024
Initiates: Buy
Price Target: $4
Current: $2.23
Upside: +79.37%
Nov 14, 2023
Downgrades: Neutral
Price Target: n/a
Current: $5.84
Upside: -
Sep 12, 2023
Downgrades: Neutral
Price Target: n/a
Current: $14.20
Upside: -
Apr 17, 2023
Maintains: Buy
Price Target: $27 → $28
Current: $14.22
Upside: +96.91%
Apr 17, 2023
Maintains: Buy
Price Target: $195 → $200
Current: $144.64
Upside: +38.27%
Apr 17, 2023
Maintains: Buy
Price Target: $340 → $350
Current: $314.52
Upside: +11.28%
Dec 17, 2021
Maintains: Buy
Price Target: $138 → $128
Current: $95.45
Upside: +34.10%
Nov 22, 2021
Initiates: Buy
Price Target: $15
Current: $11.89
Upside: +26.16%
Feb 22, 2021
Maintains: Buy
Price Target: $84 → $91
Current: $67.76
Upside: +34.30%
Sep 23, 2020
Initiates: Buy
Price Target: $42
Current: $18.17
Upside: +131.15%
Aug 14, 2020
Upgrades: Buy
Price Target: $53
Current: $5.00
Upside: +950.00%
Apr 2, 2020
Downgrades: Neutral
Price Target: n/a
Current: $15.99
Upside: -